NCT00830817View on ClinicalTrials.gov

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis

CompletedOBSERVATIONAL

Enrollment

36

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions

Psoriasis

Trial Locations (1)

H2K 4L5

Innovaderm Research inc., Montreal

All Listed Sponsors

lead

Welichem Biotech Inc.

INDUSTRY

NCT00830817 - Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis | Biotech Hunter | Biotech Hunter